Interactive Computer Treatment for Panic Disorder - Full Text View

Purpose

This study will develop an interactive computer-based version of cognitive behavioral therapy (CBT) and compare its effectiveness to book-based CBT for the treatment of panic disorder.

Condition	Intervention	Phase
Panic Disorder	Behavioral: Computer Based Cognitive Behavioral Therapy	Phase I

MedlinePlus related topics:

Panic Disorder

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study

Official Title:	Interactive Computer Treatment for Panic Disorder

Further study details as provided by National Institute of Mental Health (NIMH):

Estimated Enrollment:	60
Study Start Date:	January 2002
Primary Completion Date:	February 2007 (Final data collection date for primary outcome measure)

Detailed Description:

Panic disorder (PD) is a highly prevalent and debilitating condition. Unfortunately, many people with PD go untreated because of the high cost and low availability of treatment. Research shows that CBT is an effective treatment for PD. When administered as a self-help, computer based treatment, CBT may provide a less expensive, more engaging treatment for PD.

Participants in this study will be randomly assigned to receive computer based treatment, book based treatment, or no treatment for 10 weeks. After these 10 weeks, symptoms of anxiety and depression will be measured with patient interviews, scales, and questionnaires.

Eligibility

Ages Eligible for Study:	18 Years to 65 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

DSM-IV diagnosis of panic disorder, with or without agoraphobia

Exclusion Criteria:

Change in medication type or dose 12 weeks prior to study entry
Suicidal
Current substance abuse
Current or past schizophrenia, bipolar disorder, or organic mental disorder. Patients on medications must meet stability requirements such that initial administration of the medication and dose has been maintained for at least 3 months prior to treatment and will be maintained until post-treatment.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00063375

Locations


United States, Florida
	Florida State University
	Tallahassee, Florida, United States, 32306

Sponsors and Collaborators

National Institute of Mental Health (NIMH)

More Information

Study ID Numbers:	R21 MH62056, DSIR AT-AS
First Received:	June 25, 2003
Last Updated:	February 8, 2008
ClinicalTrials.gov Identifier:	NCT00063375
Health Authority:	United States: Federal Government

Study placed in the following topic categories:

Panic Disorder

Anxiety Disorders

Mental Disorders

Additional relevant MeSH terms:

Pathologic Processes

Disease

ClinicalTrials.gov processed this record on November 30, 2008

Sponsored by:	National Institute of Mental Health (NIMH)
Information provided by:	National Institute of Mental Health (NIMH)
ClinicalTrials.gov Identifier:	NCT00063375